A Sensitized ENU Mutagenesis Screen for Thrombosis Modifiers Identifies Suppressor Variants in Non-mutagenized Parental Generations Due to Antithrombotic Selective Pressures
Thrombosis is a leading cause of morbidity and mortality. We used a mouse forward genetic ENU screen to identify genomic variants that suppress <i>F5</i> <sup>L/L</sup> <i>Tfpi</i> <sup>+/-</sup> lethal thrombosis. Surviving <i>F5</i> <sup>L/L</sup> <i>Tfpi</i> <sup>+/-</sup> mice from our <i>M</i> odifier of <i>F</i> actor <i>5 L</i> eiden 16 ( <i>MF5L16</i> ) ENU line were subjected to whole-genome sequencing analysis. This revealed that instead of an ENU-induced mutation, four mutations introduced from our <i>F5</i> <sup>L/L</sup> breeding stock were responsible for survival, which we named <i>sMF5L1-4</i> for <i>s</i> pontaneous <i>M</i> odifier of <i>F</i> actor <i>5 L</i> eiden. In our colony, <i>F5</i> <sup>L/L</sup> female breeders carrying all four <i>sMF5L</i> mutations produced more litters and offspring than breeders with three or fewer mutations (p<0.006). Genotyping of 13 additional <i>MF5L</i> lines demonstrated that the four <i>sMF5L</i> mutations were present in all lines and were consistently associated with survival. Of these four mutations, a single G to A intergenic variant on Chromosome 18 (Chr18 <sup>A</sup> , <i>sMF5L4</i> ), was most significantly associated with survival (p=0.003), with ∼15% penetrance for conferring the survival phenotype. Furthermore, platelet aggregation was significantly reduced in Chr18 <sup>A</sup> mice, suggesting an additional mechanism by which Chr18 <sup>A</sup> could suppress lethal thrombosis. Comparative transcriptomics analysis of livers from Chr18 <sup>A</sup> mice versus wildtype littermate controls revealed a small number of differentially expressed genes both known and unknown to affect thrombosis. In summary, we have identified four variants exerting a significant selective breeding advantage along with antithrombotic effects. Superimposing our mutagenesis screen on a selective background illustrates the interplay of natural strain background variants and <i>de novo</i> ENU mutations in suppressing <i>F5</i> <sup>L/L</sup> <i>Tfpi</i> <sup>+/-</sup> lethal thrombosis.
Authors
- Justin R. Kulchycki (ORCID: https://orcid.org/0000-0002-4000-9320)
- Audrey Cleuren (ORCID: https://orcid.org/0000-0003-1384-4651)
- Amy E. Siebert (ORCID: https://orcid.org/0000-0002-9634-9164)
- Tyler M. Parsons (ORCID: https://orcid.org/0000-0003-0277-1557)
- Martijn A. van der Ent
- Marisa A Brake (ORCID: https://orcid.org/0000-0002-0385-0428)
- Adrianna Jurek (ORCID: https://orcid.org/0000-0002-9803-3155)
- Randal J. Westrick (ORCID: https://orcid.org/0000-0001-8775-8460)
- Guojing Zhu
- David Siemieniak
- Sydney J. Torres (ORCID: https://orcid.org/0009-0007-4932-6684)
- Caitlin Schneider
- Kailey H MacFadyen
- Andrew E Timms
- David R Beier
Institutions
- Seattle Children's Hospital (US)
- Oakland University (US)
- University of Michigan (US)
- Oklahoma Medical Research Foundation (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-01-25
- DOI
- https://doi.org/10.64898/2026.01.25.701592
- Primary Topic
- Blood Coagulation and Thrombosis Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute